Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Without PBS subsidy for obesity indications, patients pay full price: Wegovy: approximately $320$450 per month Saxenda: approximately $390$440 per month Mounjaro (off-label for weight loss): approximately $280$750 per month depending on dose PBS listing for obesity indications is an ongoing discussion, with health economists and advocacy groups pushing for subsidised access given the long-term healthcare costs associated with untreated obesity
SLC25A21 downregulation promotes KRAS-mutant colorectal cancer progression by increasing glutamine anaplerosis
& Herrmann, W
SKU: RNL-01 Category: Uncategorized Related Products 5mg of Selank 25 in stock Sterile DADA (diisopropylamine dichloroacetate) 100 mg/ml solution 10ml vial 20 in stock 10mg of KPV 22 in stock 10mg BPC-157 33 in stock 30 x 200 micrograms SLU-PP-332 Research chemicals are not suited for human consumption
US$ 22.42
US$ 25.70
US$ 26.41
US$ 24.01
US$ 26.16
US$ 24.94
